Physician profile
Daniel Yoo
NPI 1043779291
$4,179.33
in general payments reported to CMS, 2019-2025
19 companies · $695 in 2025
The $695 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,323 · 2022: $387 · 2023: $644 · 2024: $1,130 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,469.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $1,200.00 | 2021 | |
| Baxter Healthcare | $519.09 | 2022-2024 | Artiss |
| Integra Lifesciences Corporation | $375.48 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Axogen | $269.20 | 2024-2025 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Organogenesis INC. | $187.95 | 2024-2025 | Puraply Wound Matrix, Puraply Franchise |
| Polynovo North America LLC | $180.74 | 2024 | Novosorb Btm |
| Acera Surgical, INC. | $163.46 | 2024 | Restrata Wound Matrix |
| Avita Medical Americas, LLC | $146.32 | 2023 | Recell |
| Orthofix Medical, INC. | $142.86 | 2023 | Truelok |
| Kerecis Limited | $139.29 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Revance Therapeutics, INC. | $138.78 | 2025 | Daxi |
| Abbvie INC. | $127.89 | 2024 | |
| Mentor Worldwide LLC | $123.30 | 2021 | |
| Innovation Technologies INC | $115.02 | 2022 | |
| Sientra, INC. | $100.00 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $87.79 | 2022 | |
| Tela Bio, INC. | $83.57 | 2024 | Ovitex 2s |
| Stryker Corporation | $65.08 | 2023 | Na |
| Sanara Medtech INC. | $13.51 | 2024 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.